These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 8772676)
1. Is there a role for endothelin in the natural history of heart failure? Cohn JN Circulation; 1996 Aug; 94(4):604-6. PubMed ID: 8772676 [No Abstract] [Full Text] [Related]
12. Vasodilator therapy of cardiac failure: (first of two parts). Cohn JN; Franciosa JA N Engl J Med; 1977 Jul; 297(1):27-31. PubMed ID: 405585 [No Abstract] [Full Text] [Related]
13. Nitrates versus angiotensin-converting enzyme inhibitors for congestive heart failure. Cohn JN Am J Cardiol; 1993 Sep; 72(8):21C-24C; discussion 24C-26C. PubMed ID: 8372797 [TBL] [Abstract][Full Text] [Related]
14. [Vasodilator therapy in management of chronic heart failure (author's transl)]. Letac B; Champoud O; Moore N Therapie; 1981; 36(1):1-10. PubMed ID: 7015550 [No Abstract] [Full Text] [Related]
15. Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism. Wada A; Tsutamoto T; Ohnishi M; Sawaki M; Fukai D; Maeda Y; Kinoshita M Circulation; 1999 Feb; 99(4):570-7. PubMed ID: 9927406 [TBL] [Abstract][Full Text] [Related]
16. Current indications for vasodilator therapy for left ventricular failure. Franciosa JA Compr Ther; 1985 Mar; 11(3):39-46. PubMed ID: 2983926 [No Abstract] [Full Text] [Related]